Altamira Therapeutics Stock Return On Equity
Altamira Therapeutics fundamentals help investors to digest information that contributes to Altamira Therapeutics' financial success or failures. It also enables traders to predict the movement of Altamira Stock. The fundamental analysis module provides a way to measure Altamira Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Altamira Therapeutics stock.
Altamira |
Altamira Therapeutics Company Return On Equity Analysis
Altamira Therapeutics' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Altamira Therapeutics Return On Equity | -3.69 |
Most of Altamira Therapeutics' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Altamira Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Altamira Therapeutics has a Return On Equity of -3.6878. This is 84.61% lower than that of the Biotechnology sector and 89.89% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Altamira Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Altamira Therapeutics' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Altamira Therapeutics could also be used in its relative valuation, which is a method of valuing Altamira Therapeutics by comparing valuation metrics of similar companies.Altamira Therapeutics is currently under evaluation in return on equity category among its peers.
Altamira Fundamentals
| Return On Equity | -3.69 | |||
| Return On Asset | -0.57 | |||
| Current Valuation | 860.75 K | |||
| Shares Outstanding | 3.78 M | |||
| Shares Owned By Insiders | 0.52 % | |||
| Shares Owned By Institutions | 3.13 % | |||
| Number Of Shares Shorted | 50.63 K | |||
| Price To Book | 0.08 X | |||
| Price To Sales | 0.64 X | |||
| Gross Profit | (2.18 M) | |||
| EBITDA | (1.35 M) | |||
| Net Income | (3.87 M) | |||
| Cash And Equivalents | 984.19 K | |||
| Cash Per Share | 1.29 X | |||
| Total Debt | 99.66 K | |||
| Debt To Equity | 0.04 % | |||
| Current Ratio | 0.77 X | |||
| Book Value Per Share | 2.37 X | |||
| Cash Flow From Operations | (11.51 M) | |||
| Short Ratio | 0.52 X | |||
| Earnings Per Share | 1.82 X | |||
| Target Price | 4.92 | |||
| Number Of Employees | 10 | |||
| Beta | 2.44 | |||
| Market Capitalization | 1.13 M | |||
| Total Asset | 7.69 M | |||
| Retained Earnings | (18.05 M) | |||
| Working Capital | 334.24 K | |||
| Net Asset | 7.69 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Altamira Stock
If you are still planning to invest in Altamira Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Altamira Therapeutics' history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |